Epilepsy affects 65 million people globally, with 30% unable to control their seizures with medication. Implantable devices that control brain activity via electrical stimulation are an alternative treatment option; however, existing FDA-approved devices only render 13% of patients seizure-free for up to a year. NerveX Neurotechnologies has developed ANIMO (Adaptive Neural Implant for Modulation and […]
Read More